Literature DB >> 16000563

Effect of low glutamine/glucose on hypoxia-induced elevation of hypoxia-inducible factor-1alpha in human pancreatic cancer MiaPaCa-2 and human prostatic cancer DU-145 cells.

Seok Joon Kwon1, Yong J Lee.   

Abstract

PURPOSE AND EXPERIMENTAL
DESIGN: Tumor microenvironment is characterized by regions of fluctuating and chronic hypoxia, low extracellular pH, and nutrient depletion. Although it is well known that hypoxia stimulates the accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha), the role of low extracellular pH and nutrient depletion on hypoxia up-regulation of HIF-1alpha is not well known. In this study, human pancreatic cancer MiaPaCa-2 and human prostatic cancer DU-145 cells were exposed to hypoxia in the presence or absence of glucose, glutamine, and/or pyruvate.
RESULTS: We observed that low glucose and low glutamine, but not low pyruvate, effectively suppressed the elevation of HIF-1alpha level during hypoxia (0.1-1% oxygen). Deprivation of glutamine or glucose inhibited the accumulation of HIF-1alpha in the presence of MG-132, a protease inhibitor, regardless of oxygen tensions. Data from reverse transcription-PCR analysis revealed that the levels of HIF-1alpha mRNA were not significantly changed at different concentrations of glutamine or glucose under hypoxia. The amount of HIF-1alpha suppression was proportional to protein synthesis inhibition.
CONCLUSIONS: Our data suggest that glutamine or glucose deprivation inhibits the accumulation of HIF-1alpha under hypoxic conditions by disrupting translational processes rather than transcriptional or proteasomal degradation processes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000563     DOI: 10.1158/1078-0432.CCR-04-2530

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  23 in total

1.  Hypoxia inducible factor-1 mediates effects of insulin on pancreatic cancer cells and disturbs host energy homeostasis.

Authors:  Feng Wang; Shu Shun Li; Ralf Segersvärd; Lisa Strömmer; Karl-Gösta Sundqvist; Jan Holgersson; Johan Permert
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 2.  From Krebs to clinic: glutamine metabolism to cancer therapy.

Authors:  Brian J Altman; Zachary E Stine; Chi V Dang
Journal:  Nat Rev Cancer       Date:  2016-07-29       Impact factor: 60.716

Review 3.  Energy metabolism and proliferation in pancreatic carcinogenesis.

Authors:  Ivonne Regel; Bo Kong; Susanne Raulefs; Mert Erkan; Christoph W Michalski; Mark Hartel; Jörg Kleeff
Journal:  Langenbecks Arch Surg       Date:  2012-03-20       Impact factor: 3.445

Review 4.  Immunometabolism: A new target for improving cancer immunotherapy.

Authors:  Chunqing Guo; Shixian Chen; Wenjie Liu; Yibao Ma; Juan Li; Paul B Fisher; Xianjun Fang; Xiang-Yang Wang
Journal:  Adv Cancer Res       Date:  2019-04-17       Impact factor: 6.242

5.  Normoxic accumulation of HIF1α is associated with glutaminolysis.

Authors:  Matthias Kappler; Ulrike Pabst; Swetlana Rot; Helge Taubert; Henri Wichmann; Johannes Schubert; Matthias Bache; Claus Weinholdt; Uta-Dorothee Immel; Ivo Grosse; Dirk Vordermark; Alexander W Eckert
Journal:  Clin Oral Investig       Date:  2016-03-09       Impact factor: 3.573

6.  Excess glucose induces hypoxia-inducible factor-1α in pancreatic cancer cells and stimulates glucose metabolism and cell migration.

Authors:  Zhiwen Liu; Xiaohui Jia; Yijie Duan; Huijie Xiao; Karl-Gösta Sundqvist; Johan Permert; Feng Wang
Journal:  Cancer Biol Ther       Date:  2013-02-01       Impact factor: 4.742

7.  The real face of HIF1α in the tumor process.

Authors:  Matthias Kappler; Helge Taubert; Johannes Schubert; Dirk Vordermark; Alexander W Eckert
Journal:  Cell Cycle       Date:  2012-09-17       Impact factor: 4.534

8.  HIF-1alpha links beta-adrenoceptor agonists and pancreatic cancer cells under normoxic condition.

Authors:  Heng-tong Hu; Qing-yong Ma; Dong Zhang; Su-gang Shen; Liang Han; Ya-dong Ma; Ruo-fei Li; Ke-ping Xie
Journal:  Acta Pharmacol Sin       Date:  2009-12-28       Impact factor: 6.150

9.  Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma.

Authors:  Arnulf Mayer; Fabienne Schneider; Peter Vaupel; Clemens Sommer; Heinz Schmidberger
Journal:  Int J Oncol       Date:  2012-07-16       Impact factor: 5.650

10.  Lacking hypoxia-mediated downregulation of E-cadherin in cancers of the uterine cervix.

Authors:  A Mayer; M Höckel; N Schlischewsky; H Schmidberger; L-C Horn; P Vaupel
Journal:  Br J Cancer       Date:  2013-01-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.